by Susan | 9 May, 2024 | Biotech Perspectives
Back to Ideas Informed consent in healthcare: adding to FDA guidance In early 2024, the Food and Drug Administration (FDA) shared a draft of Key Information and Facilitating Understanding in Informed Consent — Guidance for Sponsors, Investigators, and Institutional...
by Susan | 18 Oct, 2023 | Biotech Perspectives
Back to Ideas HCP communication best practices Pharmaceutical manufacturers spend a significant amount of time and effort designing promotional materials, programs, and services to support doctors in prescribing their products. Classic communication topics of focus...
by Susan | 12 Jul, 2023 | Biotech Perspectives
Back to Ideas Patient-centred communications in pharma and biotech Internally, pharma and biotech companies are usually very focused on the patients they serve. Big meetings open with patient speakers, patient stories feature prominently in corporate communications,...
by Susan | 10 Aug, 2022 | Biotech Perspectives
Back to Ideas Treatment decision-making: a Framework The Workomics treatment decision-making framework outlines key internal and external factors that shape prescribing behaviour. Commercial pharmaceutical teams must build new strategies and tactics to drive business...
